Format

Send to

Choose Destination
BJOG. 2017 Sep;124(10):1567-1574. doi: 10.1111/1471-0528.14545. Epub 2017 Mar 15.

Timing of antenatal corticosteroid administration and survival in extremely preterm infants: a national population-based cohort study.

Author information

1
Department of Clinical Science, Intervention and Technology, Division of Pediatrics, Karolinska Institutet, Stockholm, Sweden.
2
Department of Obstetrics and Gynecology, Clinical Sciences, Lund University, Stockholm, Sweden.
3
Department of Neonatal Medicine, Karolinska University Hospital, Stockholm, Sweden.

Abstract

OBJECTIVE:

To explore the association between administration-to-birth interval of antenatal corticosteroids (ACS) and survival in extremely preterm infants.

DESIGN:

Population-based prospective cohort study.

SETTING:

All obstetric and neonatal units in Sweden from 1 April 2004 to 31 March 2007.

POPULATION:

All live-born infants (n = 707) born at 22-26 completed weeks of gestation.

METHODS:

The relationship between time from first administration of ACS to delivery and survival was investigated using Cox proportional hazards regression analysis.

MAIN OUTCOME MEASURES:

Neonatal (0-27 days) and infant (0-365 days) survival, and infant survival without major neonatal morbidity (intraventricular haemorrhage grade ≥ 3, retinopathy of prematurity stage ≥ 3, periventricular leukomalacia, necrotising enterocolitis, or severe bronchopulmonary dysplasia).

RESULTS:

Five-hundred and ninety-one (84%) infants were exposed to ACS. In the final adjusted model, infant survival was lower in infants unexposed to ACS [hazard ratio (HR) = 0.26; 95% confidence interval 0.15-0.43], in infants born <24 h [HR = 0.53 (0.33-0.87)] and >7 days after ACS [HR = 0.56 (0.32-0.97)], but not in infants born 24-47 h after ACS [HR = 1.60 (0.73-3.50)], as compared with infants born 48 h to 7 days after administration. The findings were similar for neonatal survival. Survival without major neonatal morbidity among live-born infants was 14% in unexposed infants and 30-39% in steroid-exposed groups, indicating that any ACS exposure was valuable.

CONCLUSIONS:

Administration of ACS 24 h to 7 days before extremely preterm birth was associated with significantly higher survival than in unexposed infants and in infants exposed to ACS at shorter or longer administration-to-birth intervals.

TWEETABLE ABSTRACT:

Timing of antenatal corticosteroids is important for extremely preterm infants' survival.

KEYWORDS:

Administration-to-birth interval; antenatal glucocorticoids; extremely preterm birth; major neonatal morbidity; mortality

PMID:
28294496
DOI:
10.1111/1471-0528.14545
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center